Peter Valent. On the safety of low-dose dasatinib in comorbid and non-comorbid patients: what is real-life? (Reply). haematol [Internet]. 2011Mar.31 [cited 2024Apr.25];96(4):e25-e25. Available from: https://haematologica.org/article/view/5950